Purdue Pharma L.P – Purdue CEO, Accused of Being “Author of a Sick Corporate Culture,” Has Maximum Payout under KEIP Reduced by $500K and Agrees to Waive $2.9mn Severance Package
June 15, 2022 – At a June 15th hearing, the Court approved amendments to the Debtors' key employee incentive program (the "KEIP") as it had been proposed in a an April 27th motion [Docket No. 4707]. On May 20th, the Court had previously issued an order approving the KEIP as to four members of Purdue's…